Literature DB >> 23616030

Effects of pancreatectomy on nutritional state, pancreatic function and quality of life.

J W Park1, J-Y Jang, E-J Kim, M J Kang, W Kwon, Y R Chang, I W Han, S-W Kim.   

Abstract

BACKGROUND: There are concerns about the extent of impaired endocrine and exocrine pancreatic function and poor quality of life (QoL) after pancreatectomy, but there is little information from large prospective follow-up studies.
METHODS: Consecutive patients undergoing pancreaticoduodenectomy or distal pancreatectomy between 2007 and 2011 were included. Relative bodyweight (RBW), triceps skinfold thickness (TSFT), serum protein, albumin, transferrin, fasting blood glucose, postprandial 2-h glucose (PP2), glycosylated haemoglobin A1c and stool elastase measurements, and European Organization for Research and Treatment of Cancer QLQ-C30 questionnaires were collected serially for 1 year.
RESULTS: Some 136 patients undergoing pancreatic resection completed the study. RBW and TSFT recovered to over 90 per cent of the preoperative value by 12 months, whereas transferrin, albumin and protein had returned to preoperative levels by 3 months. Diabetes mellitus, impaired fasting glucose or raised PP2 was present in 42 of 76 patients at 6 months and 36 of 76 at 12 months. Although steatorrhoea and diarrhoea had mainly resolved by 3 months, stool elastase level decreased after operation and showed no recovery. Nutritional status, pancreatic endocrine function and QoL returned to preoperative levels in 63 (46·3 per cent), 72 (52·9 per cent) and 77 (56·6 per cent) of 136 patients within 6 months of pancreatectomy. Multivariable analysis revealed that age 60 years or more, operation type, chronic pancreatitis and malignant disease had a significant impact on nutritional index, pancreatic function and QoL.
CONCLUSION: About half of all patients can expect recovery from pancreatectomy after 6 months, but those with risk factors need more careful follow-up and supportive management.
© 2013 British Journal of Surgery Society Ltd. Published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23616030     DOI: 10.1002/bjs.9146

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  25 in total

1.  Postoperative Changes in Body Composition After Pancreaticoduodenectomy Using Multifrequency Bioelectrical Impedance Analysis.

Authors:  Manabu Mikamori; Atsushi Miyamoto; Tadafumi Asaoka; Sakae Maeda; Naoki Hama; Kazuyoshi Yamamoto; Motohiro Hirao; Masataka Ikeda; Mitsugu Sekimoto; Yuichiro Doki; Masaki Mori; Shoji Nakamori
Journal:  J Gastrointest Surg       Date:  2015-12-21       Impact factor: 3.452

2.  Metformin Improves Survival in Patients with Pancreatic Ductal Adenocarcinoma and Pre-Existing Diabetes: A Propensity Score Analysis.

Authors:  S Amin; G Mhango; J Lin; A Aronson; J Wisnivesky; P Boffetta; Aimee L Lucas
Journal:  Am J Gastroenterol       Date:  2016-07-19       Impact factor: 10.864

3.  Identification of risk factors for pancreatic exocrine insufficiency after pancreaticoduodenectomy using a 13C-labeled mixed triglyceride breath test.

Authors:  Seiko Hirono; Yoshiaki Murakami; Masaji Tani; Manabu Kawai; Ken-ichi Okada; Kenichiro Uemura; Takeshi Sudo; Yasushi Hashimoto; Naoya Nakagawa; Naru Kondo; Hiroki Yamaue
Journal:  World J Surg       Date:  2015-02       Impact factor: 3.352

4.  Pancreatic Function in Chronic Pancreatitis: A Cohort Study Comparing 3 Methods of Detecting Fat Malabsorption and the Impact of Short-term Pancreatic Enzyme Replacement Therapy.

Authors:  Jefferson N Brownell; Joan I Schall; Virginia A Stallings
Journal:  Pancreas       Date:  2019-09       Impact factor: 3.327

5.  A multicenter survey on distal pancreatectomy in Italy: results of minimally invasive technique and variability of perioperative pathways.

Authors:  G Balzano; M Bissolati; U Boggi; C Bassi; A Zerbi; M Falconi
Journal:  Updates Surg       Date:  2014-11-28

6.  Prognostic Relevance of the Timing of Initiating and the Completion of Adjuvant Therapy in Patients with Resected Pancreatic Ductal Adenocarcinoma.

Authors:  Woohyung Lee; Yoo-Seok Yoon; Ho-Seong Han; Jin Young Jang; Jai Young Cho; Woohyun Jung; Wooil Kwon; YoungRok Choi; Sun-Whe Kim
Journal:  World J Surg       Date:  2017-02       Impact factor: 3.352

Review 7.  Diabetes after pancreatic surgery: novel issues.

Authors:  Marina Scavini; Erica Dugnani; Valentina Pasquale; Daniela Liberati; Francesca Aleotti; Gaetano Di Terlizzi; Giovanna Petrella; Gianpaolo Balzano; Lorenzo Piemonti
Journal:  Curr Diab Rep       Date:  2015-04       Impact factor: 4.810

8.  Intraductal Papillary Mucinous Neoplasms and the Risk of Diabetes Mellitus in Patients Undergoing Resection Versus Observation.

Authors:  Julie N Leal; T Peter Kingham; Michael I D'Angelica; Ronald P DeMatteo; William R Jarnagin; Marcia F Kalin; Peter J Allen
Journal:  J Gastrointest Surg       Date:  2015-07-10       Impact factor: 3.452

Review 9.  Amylase in drain fluid for the diagnosis of pancreatic leak in post-pancreatic resection.

Authors:  Tsetsegdemberel Bat-Ulzii Davidson; Mohammad Yaghoobi; Brian R Davidson; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2017-04-07

10.  Combination of longitudinal pancreaticojejunostomy with coring-out of the pancreatic head (Frey procedure) and distal pancreatectomy for chronic pancreatitis.

Authors:  Hideaki Sato; Masaharu Ishida; Fuyuhiko Motoi; Naoaki Sakata; Takeshi Aoki; Hideyuki Suzuki; Akihiro Yamamura; Hideaki Karasawa; Tatsuo Hata; Hideo Ohtsuka; Masamichi Mizuma; Takanori Morikawa; Hiroki Hayashi; Kei Nakagawa; Takashi Kamei; Takeshi Naitoh; Shinichi Egawa; Michiaki Unno
Journal:  Surg Today       Date:  2018-09-26       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.